Esperion Therapeutics, Inc.
ESPREsperion Therapeutics, Inc.
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.62
+0.01(0.2%)
52W $0.73 – $4.08
Quick:
8-K
Apr 2, 2026 (4 days ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 10, 2026 (3 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 10, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 3, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 12, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 6, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 4, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 8, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 7, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 13, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G
Aug 13, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K/A
Aug 11, 2025 (7 months ago)Current Report (Amendment)
Material event disclosure
Event materiality and market reaction
8-K
Aug 5, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 1, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 2, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 8, 2025 (11 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 6, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction